DTC Guidances May Extend To Labeling Materials, Abbott Exec Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The scope of the three FDA draft guidances is broader than it appears and may apply to materials distributed in physicians' offices and pharmacies, Abbott's regulatory affairs director says.
You may also be interested in...
FDA Releases DTC Guidances; "Not The Last Word" On Ads, Commissioner McClellan Says
The agency pledges further review of its guidance on direct-to-consumer advertising. Broadcast ads for drugs and enforcement actions against repeat offenders could see more attention.
U.S. Patents Could Limit President's AIDS Drug Assistance Plan, GAO Says
The U.S. Global AIDS Coordinator's Office suggests it will use its authority to purchase an FDA-approved generic antiretroviral product for which permission could not be obtained from the patent holder. FDA grants tentative approval to a South African firm for a generic co-packaged version of Combivir and Viramune.
Menactra Pricing Will Be In Line With Wyeth's Prevnar, Sanofi-Aventis Says
Sanofi-Aventis will price its meningococcal conjugate vaccine Menactra in line with Wyeth's pneumococcal vaccine Prevnar